The first Werewolf Therapeutics trade was made in Q1 2022.
Since then Ken Griffin bought shares three more times and sold shares on five occasions. The investor completely sold their stake between Q3 2024 and Q4 2024.
Avg closing price
Price range
Sold -11.5 Thousand shares
Q4 2024
Avg closing price
$2.02
Price range
$1.48
-
$3.63
Sold 82.0% shares (-52.4 Thousand shares)
Q3 2024
Avg closing price
$2.25
Price range
$1.71
-
$2.95
Increased shares by 1981.2% (+60.9 Thousand shares)
Q2 2024